Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Bayer

Bayer symbol

Bayer wins GIST approval for Stivarga in EU

Cancer drug can be used after Pfizer’s Sutent and Novartis’ Glivec

- PMLiVE

Nexavar fails late-stage breast cancer trial

Bayer’s oncology drug unable to improve progression free survival in new indication

- PMLiVE

Bayer names head of US litigation

Malini Moorthy joins from Pfizer

- PMLiVE

Bayer files eye drug Eylea for new use in EU

Aims to add branch retinal vein occlusion indication

- PMLiVE

Bayer’s CEO Dekkers to step down

And Sanofi CEO to move to US

- PMLiVE

GSK and Bayer strike new biotech cancer deals

Agreements with Orion and Adaptimmune aimed at strengthening their respective oncology pipelines

- PMLiVE

Bayer president Andreas Fibig set to depart

Will become CEO of International Flavors & Fragrances

Bayer symbol

J&J and Bayer unveil new bioincubators

Major pharma companies look to improve collaboration with start-ups

- PMLiVE

Bayer buys Merck consumer health unit

Continues trend for major pharma deals

- PMLiVE

Bayer outlines some of its digital health needs

Wants to work with startups in areas such as oncology and men's health

- PMLiVE

Bayer’s Nexavar recommended for thyroid cancer in EU

CHMP backs extra indication for cancer drug

National Institute for Health and Care Excellence NICE logo

Mixed cancer news from NICE

Agency backs Janssen’s myeloma drug but denies Bayer’s Xofigo in prostate cancer

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links